Houston, TXNCT07195916Now EnrollingIRB Ready

Solid Tumors Clinical Trial in Houston, TX

Access cutting-edge solid tumors treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.

Sponsored by Incyte Corporation

Quick Self-Assessment

See if you qualify for this Houston location

Preparing your pre-screening questions…

Expert Care in Houston

Access solid tumors specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related solid tumors treatment provided free

Apply for This Houston Location

Check if you qualify for this solid tumors clinical trial in Houston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houston site if eligible
  4. 4Begin participation

About This Solid Tumors Study in Houston

A study to evaluate the safety and tolerability of INCA036873 in participants with advanced solid tumors and hematological malignancies.

Sponsor: Incyte Corporation

Who Can Participate

Inclusion Criteria

Age ≥18 years.
ECOG performance status of 0 or 1.
Histologically confirmed:
Clear cell renal cell carcinoma (ccRCC).
Diffuse large B-cell lymphoma (DLBCL, NOS).
High-grade B-cell lymphoma (HGBCL).
Peripheral T-cell lymphoma (PTCL, incl. NOS and ALCL).
Cutaneous T-cell lymphoma (CTCL, incl. MF or SS ≥Stage IIB with B0/B1 blood involvement).
Disease progression, relapse, or refractory to prior therapy:
ccRCC: ≥1 prior line incl. ICI + TKI.
DLBCL/HGBCL: ≥2 prior lines incl. immunochemotherapy and salvage.
PTCL/CTCL: ≥1 prior systemic therapy.
Measurable disease by RECIST v1.1 (ccRCC), Lugano 2014 (lymphomas), or ISCL/USCLC/EORTC (CTCL).
Tumor tissue available for central testing.

Exclusion Criteria

Untreated or progressive CNS disease unless previously treated and stable.
Other active invasive malignancy within 2 years (except certain low-risk cancers).
Prior CD70-targeting therapy, including CAR T.
ASCT or CAR T ≤12 weeks before enrollment; prior organ or allogeneic transplant.
Unresolved ≥Grade 2 toxicity from prior therapy (with exceptions).
Primary immunodeficiency or active autoimmune disease requiring immunosuppression.
Active HBV, HCV, HIV, or other chronic infections requiring systemic therapy.
Pregnancy, breastfeeding, or unwillingness to use effective contraception. Other protocol-defined Inclusion/Exclusion Criteria may apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT07195916) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Solid Tumors Treatment Options in Houston, TX

If you're searching for solid tumors treatment options in Houston, TX, this clinical trial (NCT07195916) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all solid tumors clinical trials near you to find additional studies recruiting in your area.

More Advanced Solid Tumors Trials in Houston, TX

See all advanced solid tumors clinical trials recruiting in Houston — not just this study.

Browse Advanced Solid Tumors Trials in Houston →

Browse More Trials by Condition

Advanced Solid Tumors TrialsAll Conditions →

Ready to Join in Houston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houston, TX